Beyond the horizon: Neutrophils leading the way in the evolution of immunotherapy.
Beyond the horizon: Neutrophils leading the way in the evolution of immunotherapy.
复制标题
作者:
Cancer is a complex and dynamic disease, initiated by a multitude of intrinsic mutations and progressed with the assistance of the tissue microenvironment, encompassed by stromal cells including immune cell infiltration. The novel finding that tumors can evade anti‐cancer immune functions shaped the field of immunotherapy, which has been a revolutionary approach for the treatment of cancers. However, the development of predominantly T cell‐targeted immunotherapy approaches, such as immune checkpoint inhibition, also brought about an accumulation of evidence demonstrating other immune cell drivers of tumor progression, such as innate immune cells and notably, neutrophils. In the past decade, neutrophils have emerged to be primary mediators of multiple cancer types and even in recent years, are gaining attention for their potential use in the next generation of immunotherapies. Here, we review current immunotherapy strategies and thoroughly discuss the roles of neutrophils in cancer and novel neutrophil‐targeted methods for treating cancer. Roles of neutrophils in the tumor microenvironment (TME). A comprehensive overview of the intricate relationship between neutrophils and cancer cells in the TME. This figure shows the process of neutrophil recruitment and highlights their vital functions in the TME which may be both pro‐ or anti‐tumorigenic, including the production of reactive oxygen species (ROS), neutrophil extracellular traps (NETs), degranulation, phagocytosis, mediating antibody‐dependent cellular cytotoxicity (ADCC), and the emerging roles of neutrophils in the activation of adaptive immunity.
登录
查看更多内容
DOI:
10.1126/science.aao4227
发表时间:
2018-09-28
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Albrengues J;Shields MA;Ng D;Park CG;Ambrico A;Poindexter ME;Upadhyay P;Uyeminami DL;Pommier A;Küttner V;Bružas E;Maiorino L;Bautista C;Carmona EM;Gimotty PA;Fearon DT;Chang K;Lyons SK;Pinkerton KE;Trotman LC;Goldberg MS;Yeh JT;Egeblad M
通讯作者:
Egeblad M
DOI:
10.1038/s41571-021-00546-5
发表时间:
2021-12
期刊:
Nature reviews. Clinical oncology
影响因子:
--
作者:
Chen Y;McAndrews KM;Kalluri R
通讯作者:
Kalluri R
影响因子:
4.5
作者:
Blanter M;Gouwy M;Struyf S
通讯作者:
Struyf S
影响因子:
6
作者:
Bekes, Erin M.;Schweighofer, Bernhard;Deryugina, Elena I.
通讯作者:
Deryugina, Elena I.
影响因子:
4
作者:
Costanzo-Garvey, Diane L.;Case, Adam J.;Watson, Gabrielle F.;Alsamraae, Massar;Chatterjee, Arpita;Oberley-Deegan, Rebecca E.;Dutta, Samikshan;Abdalla, Maher Y.;Kielian, Tammy;Lindsey, Merry L.;Cook, Leah M.
通讯作者:
Cook, Leah M.